First Header Logo Second Header Logo

Connection

Peter Clark to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Peter Clark has written about Dose-Response Relationship, Drug.
Peter Clark
Connection Strength
0.016
Dose-Response Relationship, Drug
  1. Bin L, Thorburn J, Thomas LR, Clark PE, Humphreys R, Thorburn A. Tumor-derived mutations in the TRAIL receptor DR5 inhibit TRAIL signaling through the DR4 receptor by competing for ligand binding. J Biol Chem. 2007 Sep 21; 282(38):28189-94.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.